Literature DB >> 107188

Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

E Holten.   

Abstract

During the first 6 months of 1978, 114 strains of Neisseria meningitidis isolated from patients in Norway were serotyped. Among 27 group C strains, type 2 was most common, whereas 82% of the 82 group B isolates did not react with antisera to the standard serotypes 1 to 12. These strains were shown to belong to a new serotype, type 15. Also some group A and C strains had the type 15 antigen. Investigations on a possible immunoprophylaxis against group B meningococcal disease in Norway should accordingly proceed with type 15 rather than with type 2 meningococci.

Entities:  

Mesh：

Year:  1979        PMID： 107188      PMCID： PMC272987          DOI： 10.1128/jcm.9.2.186-188.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Immunologic response of man to group B meningococcal polysaccharide vaccines.

Authors:  F A Wyle; M S Artenstein; B L Brandt; E C Tramont; D L Kasper; P L Altieri; S L Berman; J P Lowenthal
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

2.  Classification of Neisseria meningitidis group B into distinct serotypes. II. Extraction of type-specific antigens for serotyping by precipitin techniques.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

3.  Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans.

Authors:  W D Zollinger; R E Mandrell; P Altieri; S Berman; J Lowenthal; M S Artenstein
Journal:  J Infect Dis       Date:  1978-06       Impact factor: 5.226

4.  Epidemiologic studies of serotype antigens common to groups B and C Neisseria meningitidis.

Authors:  R S Munford; C M Patton; G W Gorman
Journal:  J Infect Dis       Date:  1975-03       Impact factor: 5.226

5.  Carriage of Neisseria meningitidis in a semi-isolated arctic community.

Authors:  E Holten; D Bratlid; K Bøvre
Journal:  Scand J Infect Dis       Date:  1978

6.  Neisseria meningitidis infections in Northern Norway: an epidemic in 1974-1975 due mainly to group B organisms.

Authors:  K Bovre; E Holten; H Vik-Mo; A Brondbo; D Bratlid; P Bjark; P J Moe
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

7.  Role of protein serotype antigens in protection against disease due to Neisseria meningitidis.

Authors:  C E Frasch
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

8.  Meningococcal infections in Bolton, 1971-74.

Authors:  J S Farries; W Dickson; E Greenwood; T R Malhotra; J D Abbott; D M Jones
Journal:  Lancet       Date:  1975-07-19       Impact factor: 79.321

9.  An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity.

Authors:  C E Frasch; E C Gotschlich
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

10.  Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model.

Authors:  C E Frasch; J D Robbins
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307
View more
  69 in total

1.  Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide.

Authors:  Andrew D Cox; J Claire Wright; Jianjun Li; Derek W Hood; E Richard Moxon; James C Richards
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

2.  Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.

Authors:  Margaret Anne J Gidney; Joyce S Plested; Suzanne Lacelle; Philip A Coull; J Claire Wright; Katherine Makepeace; Jean-Robert Brisson; Andrew D Cox; E Richard Moxon; James C Richards
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes.

Authors:  Terje E Michaelsen; Øistein Ihle; Karen Johanne Beckstrøm; Tove K Herstad; Jan Kolberg; E Arne Høiby; Audun Aase
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

5.  Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.

Authors:  E R van der Voort; P van der Ley; J van der Biezen; S George; O Tunnela; H van Dijken; B Kuipers; J Poolman
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization.

Authors:  Adelfia Talà; Laura Cogli; Mario De Stefano; Marcella Cammarota; Maria Rita Spinosa; Cecilia Bucci; Pietro Alifano
Journal:  Infect Immun       Date:  2013-10-28       Impact factor: 3.441

7.  Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.

Authors:  P van der Ley; J van der Biezen; P Hohenstein; C Peeters; J T Poolman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.

Authors:  Leanne Peiser; Menno P J De Winther; Katherine Makepeace; Michael Hollinshead; Philip Coull; Joyce Plested; Tatsuhiko Kodama; E Richard Moxon; Siamon Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model.

Authors:  L Y Wang; C E Frasch
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.